Current and future treatments of HIV-associated dyslipidemia

Author： Bennett MT   Johns KW   Bondy GP  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.3, Iss.2, 2008-04, pp. : 175-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV‐associated pulmonary arterial hypertension: from bedside to the future

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 5, 2015-05 ,pp. : 515-528

John Wiley & Sons Inc

Access to resources Recommend Favorite

Podocytes in HIV-Associated Nephropathy

By  

Nephron Clin Pract, Vol. 106, Iss. 2, 2007-06 ,pp. : c67-c71

Karger

Access to resources Recommend Favorite

Treatment of HIV-Associated Nephropathies

By  

Nephron Clin Pract, Vol. 118, Iss. 4, 2011-02 ,pp. : c346-c354

Karger

Access to resources Recommend Favorite

HIV-Associated Malignancies

By  

Oncology Research and Treatment, Vol. 40, Iss. 3, 2017-02 ,pp. : 80-81

Karger

Access to resources Recommend Favorite

HIV-Associated Lung Cancer

By  

Oncology Research and Treatment, Vol. 40, Iss. 3, 2017-02 ,pp. : 88-92

Karger

Access to resources Recommend Favorite